Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018

被引:3
作者
Hou, Wenjing [1 ]
Li, Dandan [1 ]
Shen, Su [1 ]
Lin, Jun [2 ]
Lou, Anqi [1 ]
Wen, Aiping [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, 95 Yongan St, Beijing 100050, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China
关键词
antihypertensive agent; frequency; kidney transplant; prescribing pattern; CLINICAL-PRACTICE GUIDELINE; BLOOD-PRESSURE CONTROL; RENAL-TRANSPLANTATION; HYPERTENSION; MANAGEMENT; EFFICACY; PREVALENCE; OUTCOMES; DISEASE; NUMBER;
D O I
10.1016/j.clinthera.2021.01.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Antihypertensive agents are frequently prescribed in kidney transplant recipients (KTRs). However, the frequency and patterns of prescribing antihypertensive agents remain uncharacterized in KTRs in China. Therefore, this investigation was carried out. Methods: Retrospective prescription data dated 2011 to 2018 from KTRs in China were accessed using the Hospital Prescription Analysis Program database. Information about sex, birth date, and identification number of the patient; city, date, and department of the medical visit; major diagnoses; and the generic names, specifications, quantities, and usage of prescribed drugs were collected. Antihypertensive agents were grouped into 5 classes: angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), beta-blockers (BBs), calcium channel blockers (CCBs), and diuretics. The frequency and patterns of prescribing these antihypertensive agents were analyzed. Findings: Prescriptions from 174,749 KTRs (67.2% male; mean age, 42.5 [9.4] years) were obtained, and 58.2% of the patients were prescribed antihypertensive agents. The percentage of patients who received antihypertensive treatment increased from 52.9% in 2011 to 61.6% in 2018 and varied by city. Cyclosporine was associated with higher prescription frequency of antihypertensive agents than was tacrolimus (71.7% vs 63.4%; P < 0.0001). During the 8-year study period, CCBs were most frequently prescribed (39.0%), followed by ARBs (31.9%), BBs (14.3%), ACEIs (11.6%), and diuretics (3.2%). The mean (SD) number of antihypertensive drugs prescribed per KTR was 1.7 (0.8). Almost half of KTRs (51.2%) received just 1 antihypertensive drug. Co-administration of 2 or more antihypertensive drugs presented an obviously upward trend. The most commonly prescribed 2-drug combination was CCB + ARB (44.8%), followed by CCB + BB (20.1%) and CCB + ACEI (13.0%). In the patients who received 3 antihypertensive drugs, the 2 most frequently prescribed combinations were CCB + ARB + BB (37.5%) and CCB + ARB + ACEI (32.7%). Specific data varied by both year and city. (C) 2021 Elsevier Inc.
引用
收藏
页码:602 / 612
页数:11
相关论文
共 35 条
[1]   Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study [J].
Adrych, D. ;
Kuzmiuk-Glembin, I. ;
Tylicki, L. ;
Heleniak, Z. ;
Garnier, H. ;
Wisniewski, J. ;
Rutkowski, P. ;
Rutkowski, B. ;
Debska-Slizien, A. .
TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) :155-159
[2]  
[Anonymous], 2019, Hypertension in adults: diagnosis and management
[3]   Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: An updated systematic review and meta-analysis [J].
Azarfar, Anoush ;
Ravanshad, Yalda ;
Mehrad-Majd, Hassan ;
Esmaeeli, Mohammad ;
Aval, Shapour Badiei ;
Emadzadeh, Maryam ;
Salehi, Maryam ;
Moradi, Ali ;
Golsorkhi, Mohadese ;
Khazaei, Mahmood Reza .
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2018, 29 (06) :1376-1385
[4]   Hypertension guidelines: How do they apply to kidney transplant recipients [J].
Aziz, Fahad ;
Clark, Dana ;
Garg, Neetika ;
Mandelbrot, Didier ;
Djamali, Arjang .
TRANSPLANTATION REVIEWS, 2018, 32 (04) :225-233
[5]  
Branch of Organ Transplantation of Chinese Medical Association, 2019, ORGAN TRANSPL, V10, P112
[6]   Management of hypertension and factors affecting its control in Jordanian renal transplant recipients [J].
Bulatova, Nailya ;
Yousef, Al-Motassem ;
Qusa, Hisham ;
Al Khayat, Ghada ;
Ailabouni, Wadad ;
Wahbeh, Ayman ;
Al-Ulemat, Muhammad .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (03) :439-444
[7]   BP, Cardiovascular Disease, and Death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial [J].
Carpenter, Myra A. ;
John, Alin ;
Weir, Matthew R. ;
Smith, Stephen R. ;
Hunsicker, Lawrence ;
Kasiske, Bertram L. ;
Kusek, John W. ;
Bostom, Andrew ;
Ivanova, Anastasia ;
Levey, Andrew S. ;
Solomon, Scott ;
Pesavento, Todd ;
Weiner, Daniel E. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (07) :1554-1562
[8]  
Chinese Medical Association (CMA), REPORT ORGAN TRANSPL
[9]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[10]  
Divac N, 2017, HERZ, V42, P67, DOI 10.1007/s00059-016-4431-7